Shouyao Holdings (Beijing) Co. Ltd. A (688197.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE1000062V6
Shouyao Holdings (Beijing) Co. Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.94 m CNY | 8.67 m CNY |
| Gross profit | 3.90 m CNY | 8.40 m CNY |
| Operating income | -225.86 m CNY | -146.43 m CNY |
| EBIT | -211.75 m CNY | -128.70 m CNY |
| Net income | -211.94 m CNY | -128.83 m CNY |
| Diluted EPS – continuing operations | -1.43 CNY | -0.87 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.
More stocks
- Pharming Group NV (PHARM.AS)
- SNP Schneider-Neureither & Partner (SHF.DE)
- Cadillac Mines Corporation (CADY.TO)
- Schaltbau Holding (SLT.HM)
- SOUTHERN MISSOURI BANCORP, INC. (SMBC)
- Krispy Kreme, Inc. (DNUT)
- Logan Group Co Ltd (3380.HK)
- Jiangsu Jibeier Pharmaceutical Co Ltd (688566.SS)
- Iress Ltd (IRE.AX)
- Standard Foods Corp (1227.TW)
- SK IE Technology Co Ltd (361610.KS)
- Zhejiang Jihua Group Co Ltd (603980.SS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.